These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31571874)

  • 1. Investigation Of Vitamin B
    Long L; Lai M; Mao X; Luo J; Yuan X; Zhang LM; Ke Z; Yang L; Deng DY
    Int J Nanomedicine; 2019; 14():7743-7758. PubMed ID: 31571874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory Fucoidan-ConA oral insulin nanosystems for smart blood glucose regulation.
    Zhou J; Ma H; Guan M; Feng J; Dong X; Wei Y; Zhang T
    Int J Pharm; 2024 Jun; 659():124250. PubMed ID: 38777304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting Apical Sodium-Dependent Bile Acid Transporter (ASBT)-Mediated Endocytosis with Multi-Functional Deoxycholic Acid Grafted Alginate Amide Nanoparticles as an Oral Insulin Delivery System.
    Razmjooei M; Hosseini SMH; Yousefi G; Golmakani MT; Eskandari MH
    Pharm Res; 2024 Feb; 41(2):335-353. PubMed ID: 38114803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability.
    Lamson NG; Berger A; Fein KC; Whitehead KA
    Nat Biomed Eng; 2020 Jan; 4(1):84-96. PubMed ID: 31686002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-nanoemulsifying system improves oral absorption and enhances anti-acute myeloid leukemia activity of berberine.
    Li J; Yang L; Shen R; Gong L; Tian Z; Qiu H; Shi Z; Gao L; Sun H; Zhang G
    J Nanobiotechnology; 2018 Oct; 16(1):76. PubMed ID: 30290822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral sericin ameliorates type 2 diabetes through passive intestinal and bypass transport into the systemic circulation.
    Zhang J; Wang F; Zhong H; Pi J; Chen G; Chen Z
    J Ethnopharmacol; 2024 Oct; 332():118342. PubMed ID: 38750984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral delivery of proteins and peptides: Challenges, status quo and future perspectives.
    Zhu Q; Chen Z; Paul PK; Lu Y; Wu W; Qi J
    Acta Pharm Sin B; 2021 Aug; 11(8):2416-2448. PubMed ID: 34522593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nanoparticle size, shape and surface chemistry in oral drug delivery.
    Banerjee A; Qi J; Gogoi R; Wong J; Mitragotri S
    J Control Release; 2016 Sep; 238():176-185. PubMed ID: 27480450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-loaded pH-sensitive hyaluronic acid nanoparticles enhance transcellular delivery.
    Han L; Zhao Y; Yin L; Li R; Liang Y; Huang H; Pan S; Wu C; Feng M
    AAPS PharmSciTech; 2012 Sep; 13(3):836-45. PubMed ID: 22644708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms.
    Liu L; Yao W; Rao Y; Lu X; Gao J
    Drug Deliv; 2017 Nov; 24(1):569-581. PubMed ID: 28195032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functionalized zein nanoparticles targeting neonatal Fc receptor to enhance lung absorption of peptides.
    Hameedat F; Pinto S; Marques J; Dias S; Sarmento B
    Drug Deliv Transl Res; 2023 Jun; 13(6):1699-1715. PubMed ID: 36587110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Improvement of Intestinal and Transmucosal Absorption of Peptide and Protein Drugs].
    Yamamoto A
    Yakugaku Zasshi; 2024; 144(7):697-714. PubMed ID: 38945845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogel-encapsulated medium chain lipid-modified zeolite imidazole framework-90 as a promising platform for oral delivery of proteins.
    Ji W; Zhang P; Zhou Y; Zhou X; Ma X; Tan T; Cao H
    J Control Release; 2024 Mar; 367():93-106. PubMed ID: 38237690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of oral permeation enhancers with lipid membranes in simulated intestinal environments.
    Larsen NW; Kostrikov S; Hansen MB; Hjørringgaard CU; Larsen NB; Andresen TL; Kristensen K
    Int J Pharm; 2024 Apr; 654():123957. PubMed ID: 38430950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced oral and pulmonary delivery of biomacromolecules via amplified transporter targeting.
    Xiao X; Zhang L; Ni M; Liu X; Xing L; Wu L; Zhou Z; Li L; Wen J; Huang Y
    J Control Release; 2024 Jun; 370():152-167. PubMed ID: 38641020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Progress of Chitosan and Chitosan Derivatives-Based Nanoparticles: Pharmaceutical Perspectives of Oral Insulin Delivery.
    Seyam S; Nordin NA; Alfatama M
    Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33066443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies.
    Chen G; Kang W; Li W; Chen S; Gao Y
    Theranostics; 2022; 12(3):1419-1439. PubMed ID: 35154498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted nanoparticles towards increased L cell stimulation as a strategy to improve oral peptide delivery in incretin-based diabetes treatment.
    Xu Y; De Keersmaecker H; Braeckmans K; De Smedt S; Cani PD; Préat V; Beloqui A
    Biomaterials; 2020 Oct; 255():120209. PubMed ID: 32580098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Insulin Delivery: A Review on Recent Advancements and Novel Strategies.
    Barfar A; Alizadeh H; Masoomzadeh S; Javadzadeh Y
    Curr Drug Deliv; 2024; 21(6):887-900. PubMed ID: 37202888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles: Oral Delivery for Protein and Peptide Drugs.
    Cao SJ; Xu S; Wang HM; Ling Y; Dong J; Xia RD; Sun XH
    AAPS PharmSciTech; 2019 May; 20(5):190. PubMed ID: 31111296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.